Cargando…
Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103530/ https://www.ncbi.nlm.nih.gov/pubmed/33676293 http://dx.doi.org/10.1016/j.esmoop.2021.100063 |
| _version_ | 1783689325472382976 |
|---|---|
| author | Corti, C. Criscitiello, C. |
| author_facet | Corti, C. Criscitiello, C. |
| author_sort | Corti, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8103530 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81035302021-05-14 Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer Corti, C. Criscitiello, C. ESMO Open Editorial Elsevier 2021-03-03 /pmc/articles/PMC8103530/ /pubmed/33676293 http://dx.doi.org/10.1016/j.esmoop.2021.100063 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Editorial Corti, C. Criscitiello, C. Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer |
| title | Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer |
| title_full | Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer |
| title_fullStr | Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer |
| title_full_unstemmed | Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer |
| title_short | Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer |
| title_sort | tucatinib approval by ema expands options for her2-positive locally advanced or metastatic breast cancer |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103530/ https://www.ncbi.nlm.nih.gov/pubmed/33676293 http://dx.doi.org/10.1016/j.esmoop.2021.100063 |
| work_keys_str_mv | AT cortic tucatinibapprovalbyemaexpandsoptionsforher2positivelocallyadvancedormetastaticbreastcancer AT criscitielloc tucatinibapprovalbyemaexpandsoptionsforher2positivelocallyadvancedormetastaticbreastcancer |